R&D

Research & Development Pipeline

Area Asset/ Partner Indication Development Pre-clinical Clinical Regulatory Submission

Oncology

Angrelide

NSCLC

 

Central Nervous System

ZolpiMist™

Insomnia

 

Sumatriptan

Migraine

 

Medical Grade Cannabis

Zelira Therapeutics

Not disclosed

 

Cann Pharma

Drug resistant epilepsy, melonoma, motion sickness

 

Development Partnership

Ordesa

Not disclosed

 

Sanofi

Not disclosed